Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical ...
The resignation of head drug regulator George Tidmarsh comes amid concerns about conduct related to the lupus nephritis drug ...
George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...
The drama continued Monday with senior FDA leaders as more details emerged about former Center for Drug Evaluation and ...
Dr. George Tidmarsh, the FDA drug regulator who was placed on leave and complained of a “toxic” work environment in an ...
It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...
Aurinia alleges that Tidmarsh’s statements were not only inaccurate but also motivated by a personal vendetta against Kevin ...
The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...
Head of FDA’s drug center George Tidmarsh is the latest member to see his name in headlines. On Friday, October 31, FDA ...
Less than 24 hours after resigning his post as the FDA’s head drug regulator, George Tidmarsh is reportedly reconsidering his decision and vowing to fight for his name and credibility amid a probe ...
The FDA's top drug regulator, Dr. George Tidmarsh, quit after federal officials began reviewing "serious concerns about his ...
An alleged extortion attempt, a petty yearslong grudge, shocking social media posts, and ominous text messages make up the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback